JavaScript is disabled in your browser. Please enable JavaScript to view this website.
AB32219

Anti-PIAS1 antibody

4

(6 Reviews)

|

(19 Publications)

Rabbit Polyclonal PIAS1 antibody. Suitable for WB, ICC/IF and reacts with Recombinant full length protein, Mouse, Human samples. Cited in 19 publications.

View Alternative Names

DDXBP1, PIAS1, E3 SUMO-protein ligase PIAS1, DEAD/H box-binding protein 1, E3 SUMO-protein transferase PIAS1, Gu-binding protein, Protein inhibitor of activated STAT protein 1, RNA helicase II-binding protein, GBP

5 Images
Immunocytochemistry/ Immunofluorescence - Anti-PIAS1 antibody (AB32219)
  • ICC/IF

Unknown

Immunocytochemistry/ Immunofluorescence - Anti-PIAS1 antibody (AB32219)

ICC/IF image of ab32219 stained MEF1 cells. The cells were methanol fixed (5 min), permabilised in TBS-T (20 min) and incubated with the antibody (ab32219, 1μg/ml) for 1h at room temperature. 1%BSA / 10% normal serum / 0.3M glycine was used to quench autofluorescence and block non-specific protein-protein interactions. The secondary antibody (green) was Alexa Fluor® 488 goat anti-rabbit IgG (H+L) used at a 1/1000 dilution for 1h. Alexa Fluor® 594 WGA was used to label plasma membranes (red). DAPI was used to stain the cell nuclei (blue).

Western blot - Anti-PIAS1 antibody (AB32219)
  • WB

Unknown

Western blot - Anti-PIAS1 antibody (AB32219)

ab32219 was used in western blot analysis using HeLa whole cell lysate, HeLa nuclear lysate and T47D nuclear lysate. It was unable to detect endogenous PIAS1 in these lysates. It was able to detect PIAS1 in cells that are overexpressing the protein, running at a molecular weight of approximately 81kDa, suggesting that the amount of endogenous PIAS1 in these cells is very low. When ab32219 was used to immunoprecipitate the PIAS1 from these extracts, the protein could then be detected by western blot in the overexpressing HeLa extract as well as the T47D nuclear extract.For immunoprecipitations, 25ug of extract was used in the IP, and 10% of the sample was run on the gel.

All lanes:

Western blot - Anti-PIAS1 antibody (ab32219) at 1/1000 dilution

Lane 1:

HeLa whole cell lysate at 25 µg

Lane 2:

HeLa whole cell extract with transfected PIAS1 at 25 µg

Lane 3:

HeLa nuclear extract at 25 µg

Lane 4:

T47D nuclear extract at 25 µg

Lane 5:

HeLa whole cell lysate immunoprecipitated with ab32219

Lane 6:

HeLa whole cell extract with transfected PIAS1 immunoprecipitated with ab32219

Lane 7:

HeLa nuclear extract immunoprecipitated with ab32219

Lane 8:

T47D nuclear extract immunoprecipitated with ab32219

Predicted band size: 71 kDa

Observed band size: 110 kDa,79 kDa,81 kDa

false

Western blot - Anti-PIAS1 antibody (AB32219)
  • WB

Unknown

Western blot - Anti-PIAS1 antibody (AB32219)

All lanes:

Western blot - Anti-PIAS1 antibody (ab32219) at 1 µg/mL

All lanes:

Human testis tissue lysate - total protein (<a href='/en-us/products/unavailable/human-testis-tissue-lysate-total-protein-ab30257'>ab30257</a>) at 10 µg

Secondary

All lanes:

Goat polyclonal Secondary Antibody to Rabbit IgG - H&L (HRP), pre-adsorbed at 1/5000 dilution

Predicted band size: 71 kDa

Observed band size: 180 kDa,72 kDa

true

Exposure time: 4min

Western blot - Anti-PIAS1 antibody (AB32219)
  • WB

Project

Western blot - Anti-PIAS1 antibody (AB32219)
ab32219 recognizes the full length tagged recombinant protein which has an expected molecular weight of 98 kDa.

All lanes:

Western blot - Anti-PIAS1 antibody (ab32219) at 1 µg/mL

All lanes:

PIAS1 - Recombinant Protein at 0.1 µg

Secondary

All lanes:

Goat polyclonal to Rabbit IgG - H&L - Pre-Adsorbed (HRP) at 1/3000 dilution

Predicted band size: 71 kDa

Observed band size: 100 kDa

false

Exposure time: 2min

Western blot - Anti-PIAS1 antibody (AB32219)
  • WB

AbReview36742****

Western blot - Anti-PIAS1 antibody (AB32219)

All lanes:

Western blot - Anti-PIAS1 antibody (ab32219) at 1/2500 dilution

Lane 1:

293T cell lysate at 25 µg

Lane 2:

MEL cell lysate at 25 µg

Lane 3:

K562 cell lysate at 25 µg

Secondary

All lanes:

Western blot - Donkey Anti-Rabbit IgG H&L (HRP) (<a href='/en-us/products/secondary-antibodies/donkey-rabbit-igg-h-l-hrp-ab6802'>ab6802</a>) at 1/20000 dilution

Predicted band size: 71 kDa

Observed band size: 71 kDa

true

Exposure time: 1min

This image is courtesy of an Abreview submitted by Min young Kim

Key facts

Host species

Rabbit

Clonality

Polyclonal

Isotype

IgG

Carrier free

No

Reacts with

Mouse, Human

Applications

ICC/IF, WB

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "guaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Mouse": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "<p></p>" }, "Rat": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Chicken": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Dog": { "WB-species-checked": "predicted", "WB-species-dilution-info": "", "WB-species-notes": "", "ICCIF-species-checked": "predicted", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" }, "Recombinant full length protein": { "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/500 - 1/2000", "WB-species-notes": "<p></p>", "ICCIF-species-checked": "notRecommended", "ICCIF-species-dilution-info": "", "ICCIF-species-notes": "" } } }

Properties and storage information

Form
Liquid
Purification technique
Affinity purification Immunogen
Storage buffer
pH: 7.4 Preservative: 0.02% Sodium azide Constituents: PBS, 1% BSA
Shipped at conditions
Blue Ice
Appropriate short-term storage duration
1-2 weeks
Appropriate short-term storage conditions
+4°C
Appropriate long-term storage conditions
-20°C
Aliquoting information
Upon delivery aliquot
Storage information
Avoid freeze / thaw cycle

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

PIAS1 also known as Protein Inhibitor of Activated STAT 1 functions as a E3 SUMO-protein ligase which regulates protein function and localization through sumoylation. It has a molecular mass of approximately 70 kDa. PIAS1 is widely expressed in a variety of tissues indicating its involvement in diverse cellular functions. This protein binds to target proteins and modulates their activity impacting how cells respond to different stimuli.
Biological function summary

PIAS1 influences transcription regulation and gene expression. It acts as a transcriptional co-regulator by interacting with various transcription factors and modulating their activity. PIAS1 is part of multiprotein complexes that mediate these regulatory processes. Its activity is important for maintaining a balanced gene expression which if uncontrolled may result in abnormal cell behavior.

Pathways

PIAS1 plays an important role in signal transduction pathways such as the JAK/STAT pathway and the NF-kB signaling pathway. It interacts with proteins like STAT an important component in these pathways to regulate immune responses and cell growth. PIAS1 modulates the activity of these pathways in part by the covalent attachment of the small ubiquitin-like modifier (SUMO) proteins demonstrating its importance in cellular signaling networks.

PIAS1 relates closely to cancer progression and autoimmune diseases. Abnormal PIAS1 function or expression has links to certain cancers due to its role in controlling cell proliferation and differentiation. In autoimmune disorders PIAS1 affects immune regulation through its interaction with Signal Transducer and Activator of Transcription proteins showing altered activity in diseases like rheumatoid arthritis. Understanding PIAS1's contributions to these pathological states helps in developing targeted therapies.

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Target data

Functions as an E3-type small ubiquitin-like modifier (SUMO) ligase, stabilizing the interaction between UBE2I and the substrate, and as a SUMO-tethering factor (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 21965678, PubMed : 36050397). Catalyzes sumoylation of various proteins, such as CEBPB, MRE11, MTA1, PTK2 and PML (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 21965678, PubMed : 36050397). Plays a crucial role as a transcriptional coregulation in various cellular pathways, including the STAT pathway, the p53 pathway and the steroid hormone signaling pathway (PubMed : 11583632, PubMed : 11867732). In vitro, binds A/T-rich DNA (PubMed : 15133049). The effects of this transcriptional coregulation, transactivation or silencing, may vary depending upon the biological context (PubMed : 11583632, PubMed : 11867732, PubMed : 14500712, PubMed : 21965678, PubMed : 36050397). Mediates sumoylation of MRE11, stabilizing MRE11 on chromatin during end resection (PubMed : 36050397). Sumoylates PML (at 'Lys-65' and 'Lys-160') and PML-RAR and promotes their ubiquitin-mediated degradation (By similarity). PIAS1-mediated sumoylation of PML promotes its interaction with CSNK2A1/CK2 which in turn promotes PML phosphorylation and degradation (By similarity). Enhances the sumoylation of MTA1 and may participate in its paralog-selective sumoylation (PubMed : 21965678). Plays a dynamic role in adipogenesis by promoting the SUMOylation and degradation of CEBPB (By similarity). Mediates the nuclear mobility and localization of MSX1 to the nuclear periphery, whereby MSX1 is brought into the proximity of target myoblast differentiation factor genes (By similarity). Also required for the binding of MSX1 to the core enhancer region in target gene promoter regions, independent of its sumoylation activity (By similarity). Capable of binding to the core enhancer region TAAT box in the MYOD1 gene promoter (By similarity).. (Microbial infection) Restricts Epstein-Barr virus (EBV) lytic replication by acting as an inhibitor for transcription factors involved in lytic gene expression (PubMed : 29262325). The virus can use apoptotic caspases to antagonize PIAS1-mediated restriction and express its lytic genes (PubMed : 29262325).
See full target information PIAS1

Publications (19)

Recent publications for all applications. Explore the full list and refine your search

Immunity, inflammation and disease 11:e819 PubMed37102653

2023

Mmu_circ_0000037 inhibits the progression of acute pancreatitis by miR-92a-3p/Pias1 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Hua Chen,Jun Tu,Lei He,Ning Gao,Weiqiang Yang

International journal of molecular sciences 23: PubMed35742810

2022

Structural and Functional Insights into CP2c Transcription Factor Complexes.

Applications

Unspecified application

Species

Unspecified reactive species

Seung Han Son,Min Young Kim,Eunbi Jo,Vladimir N Uversky,Chul Geun Kim

Nucleic acids research 50:3922-3943 PubMed35253893

2022

ZMYM2 restricts 53BP1 at DNA double-strand breaks to favor BRCA1 loading and homologous recombination.

Applications

Unspecified application

Species

Unspecified reactive species

Doohyung Lee,Katja Apelt,Seong-Ok Lee,Hsin-Ru Chan,Martijn S Luijsterburg,Justin W C Leung,Kyle M Miller

Movement disorders : official journal of the Movement Disorder Society 37:767-777 PubMed34951052

2021

A PIAS1 Protective Variant S510G Delays polyQ Disease Onset by Modifying Protein Homeostasis.

Applications

Unspecified application

Species

Unspecified reactive species

Yan Hua Lee,Yu-Shuen Tsai,Che-Chang Chang,Chun-Chen Ho,Hsiu-Ming Shih,Hui-Mei Chen,Hsing-Lin Lai,Chia-Wei Lee,Yi-Chung Lee,Yi-Chu Liao,Ueng-Cheng Yang,Tzu-Hao Cheng,Yijuang Chern,Bing-Wen Soong

FASEB journal : official publication of the Federation of American Societies for Experimental Biology 35:e21230 PubMed33769609

2021

CDKN2A deregulation in fatty liver disease and its accelerative role in the process of lipogenesis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhi Zhang,Huiqing Wen,Bangjian Peng,Jun Weng,Fanhong Zeng

Cardiovascular diagnosis and therapy 10:738-751 PubMed32968630

2020

Hypermethylation of miR-181b in monocytes is associated with coronary artery disease and promotes M1 polarized phenotype via PIAS1-KLF4 axis.

Applications

Unspecified application

Species

Unspecified reactive species

Zhonghua Wang,Chunlei Li,Xinyong Sun,Zhuqin Li,Jia Li,Lanfeng Wang,Yanming Sun

Psychoneuroendocrinology 120:104800 PubMed32688147

2020

SUMO E3 ligase PIAS1 is a potential biomarker indicating stress susceptibility.

Applications

Unspecified application

Species

Unspecified reactive species

Hsiao-Yun Lin,Yu-Shu Liu,Ching-Ya Huang,Flurin Cathomas,Kalena Liu,Jun Wang,Han-Tsung Cheng,Sheng-Wei Lai,Yu-Ching Liu,Chao-Jung Chen,Chingju Lin,Dah-Yuu Lu

The Journal of clinical investigation 129:786-801 PubMed30480549

2019

Single-dose radiotherapy disables tumor cell homologous recombination via ischemia/reperfusion injury.

Applications

Unspecified application

Species

Unspecified reactive species

Sahra Bodo,Cécile Campagne,Tin Htwe Thin,Daniel S Higginson,H Alberto Vargas,Guoqiang Hua,John D Fuller,Ellen Ackerstaff,James Russell,Zhigang Zhang,Stefan Klingler,HyungJoon Cho,Matthew G Kaag,Yousef Mazaheri,Andreas Rimner,Katia Manova-Todorova,Boris Epel,Joan Zatcky,Cristian R Cleary,Shyam S Rao,Yoshiya Yamada,Michael J Zelefsky,Howard J Halpern,Jason A Koutcher,Carlos Cordon-Cardo,Carlo Greco,Adriana Haimovitz-Friedman,Evis Sala,Simon N Powell,Richard Kolesnick,Zvi Fuks

Journal of proteome research 18:182-190 PubMed30351951

2018

Targeted Ubiquitin-Proteasomal Proteolysis Pathway in Chronic Social Defeat Stress.

Applications

Unspecified application

Species

Unspecified reactive species

Hsiao-Yun Lin,Yu-Shu Liu,Yu-Ching Liu,Chao-Jung Chen,Dah-Yuu Lu

Nucleus (Austin, Tex.) 9:87-94 PubMed29095668

2017

SUMO modification system facilitates the exchange of histone variant H2A.Z-2 at DNA damage sites.

Applications

Unspecified application

Species

Unspecified reactive species

Atsuhiko Fukuto,Masae Ikura,Tsuyoshi Ikura,Jiying Sun,Yasunori Horikoshi,Hiroki Shima,Kazuhiko Igarashi,Masayuki Kusakabe,Masahiko Harata,Naoki Horikoshi,Hitoshi Kurumizaka,Yoshiaki Kiuchi,Satoshi Tashiro
View all publications

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.
For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com